This work mitigates a big issue with the first gene drive systems, which is the accumulation of drive-resistant mosquitoes that could still transmit malaria parasites,” said UCI vector biologist Anthony James. Steve Zylius / UCI
New CRISPR-based gene drive approach successfully overcomes issue of resistance in females
Employing a strategy known as “population modification,” which involves using a CRISPR-Cas9 gene drive system to introduce genes preventing parasite transmission into mosquito chromosomes, University of California researchers have made a major advance in the use of genetic technologies to control the transmission of malaria parasites.
University of California, Irvine postdoctoral researcher Adriana Adolfi, in collaboration with colleagues at UCI, UC Berkeley and UC San Diego, followed up on the group’s pioneering effort to develop CRISPR-based gene drive systems for making mosquito vectors resistant to transmitting malaria parasites by increasing gene drive effectiveness in female mosquito progeny.
“This work mitigates a big issue with the first gene drive systems, which is the accumulation of drive-resistant mosquitoes that could still transmit malaria parasites,” said UCI vector biologist Anthony James, the Donald Bren Professor of Microbiology & Molecular Genetics and Molecular Biology & Biochemistry, who was a co-primary investigator on the study.
“The second-generation gene drive system described in this paper can be applied to any of the several thousand genes that are essential for insects to survive or reproduce,” said UC San Diego Distinguished Professor Ethan Bier, a co-author of the study and science director at the Tata Institute for Genetics and Society. “While it was developed in fruit flies, this system is readily transportable to a broad selection of insect species that serve as vectors for devastating disorders such as Chagas disease, sleeping disease, leishmaniasis and arboviral diseases.”
Study results appear in Nature Communications. Link to study: https://www.nature.com/articles/s41467-020-19426-0
They describe a highly efficient second-generation version of the team’s original gene drive, developed for the Indo-Pakistani malaria vector mosquito Anopheles stephensi. The 2015 work, published in Proceedings of the National Academy of Sciences, was the first demonstration of a CRISPR-based gene drive in mosquitoes.
In that first study, the gene drive was transmitted to about 99 percent of progeny when the parent in which the gene drive was inserted was a male but only 60 to 70 percent of offspring when the parent in which the gene drive was inserted was a female. A significant number of drive-resistant chromosomes are generated in females; this, in principle, could allow those females to continue to transmit parasites.
Adolfi, lead author of the new study, and collaborators solved the failure to drive efficiently through females by equipping the gene drive with a functional copy of the target gene into which the drive is inserted. Normal function of this target gene is required in this mosquito species for female survival and fertility after she feeds on blood, and its functionality is usually disrupted when the drive system is inserted into the gene.
The resulting female mosquitoes showed strong and consistent drive in a population cage study and negligible production of drive-resistant chromosomes. This strategy of inserting a gene drive into a gene essential for viability or fertility and at the same time including a functional gene that rescues the loss of viability or fertility provides a general solution to drive resistance through females. Also, as with a catalytic converter removing combustion pollution from automobiles, the new system efficiently eliminates genetic errors made in the drive process.
This gene drive system – in combination with genes for blocking parasite transmission – can now be used to design field-ready strains of mosquitoes. Thorough testing is required to demonstrate safety and efficacy before advancing to field testing.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Blocking malaria transmission
- South African Scientists Make ‘Breakthrough’ in Killing Malaria Before It’s Infectiouson January 21, 2021 at 3:25 am
South African scientists have identified a new chemical compound that has the ability to treat malaria and even kill the malaria parasite before it becomes infectious. The discovery was made by ...
- Newly discovered chemical could be a solution to malariaon January 20, 2021 at 10:44 am
Patients can only then be cured of the disease. It is important to block the malaria transmission cycle. Birkholtz said: “In an innovative strategy, the team looked for chemical compounds that are ...
- Scientists artificially infect mosquitoes with human malaria to advance treatmenton January 14, 2021 at 11:13 am
Koekemoer and her team at WRIM established a unique mosquito malaria infection center in the Faculty of Health Sciences at Wits University, where the mosquito transmission blocking experiments ...
- Scientists artificially infect mosquitoes with human malaria to advance treatmenton January 14, 2021 at 10:53 am
Scientists have identified novel antiplasmodial lead compounds for mass drug administration and vector control to eliminate malaria. Lead compounds are chemical compounds that show promise as ...
- Scientists discover new method in malaria treatment researchon January 14, 2021 at 9:21 am
said the team established a mosquito malaria infection centre at the Faculty of Health Sciences at Wits University, where the mosquito transmission blocking experiments took place. “The WRIM ...
Go deeper with Google Headlines on:
Blocking malaria transmission
Go deeper with Bing News on:
CRISPR-based gene drive
- KSQ® Therapeutics Appoints Qasim Rizvi, MB ChB., M.B.A., as Chief Executive Officeron January 25, 2021 at 4:14 am
KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics ® discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune ...
- Emmanuelle Charpentier And Jennifer Doudna Sharpened Mother Nature’s Genetic Scissors And Won The Nobel For Iton January 21, 2021 at 4:00 pm
Dr. Doudna discusses some of those methods in this interview with Future Human shortly after her Nobel win. Her company Mammoth Biosciences is working on a rapid CRISPR-based test for COVID-19 and ...
- Chinese scientists develop gene therapy that could delay ageingon January 19, 2021 at 5:00 pm
A new gene therapy has been shown to reverse some of the effects of ageing in mice and extend their lifespans by up to a quarter. Chinese researchers used CRISPR-Cas9, a powerful gene-editing ...
- DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologieson January 18, 2021 at 6:45 pm
Mammoth Biosciences will apply its DETECTR™ platform, and IDbyDNA, its proprietary pathogen database and algorithms, toward the development of CRISPR-based diagnostics and biosurveillance technologies ...
- COVID-19 Pandemic to Open New Avenues for Global CRISPR and Cas Genes Market Growth, Predicts Fact.MRon January 13, 2021 at 2:10 am
CRISPR-based diagnostics have been gaining momentum ... other human diseases and wide application areas are anticipated to drive growth of both segments. • By application, genomic engineering ...